Market Place
Sourcing Support
CoreRx, Societal CDMO, Bend Bioscience Unite Under Bend Bioscience Brand
04 Sep 2024 //
PR NEWSWIRE
CoreRx Completes Acquisition of Societal CDMO
09 Apr 2024 //
CONTRACTPHARMA
Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.
28 Feb 2024 //
GLOBENEWSWIRE
Societal CDMO and Benuvia Sign Co-Marketing Agreement
01 Feb 2024 //
GLOBENEWSWIRE
Societal CDMO Reports Inducement Grants for New Staff
05 Jan 2024 //
GLOBENEWSWIRE
Societal CDMO Reports Third Quarter 2023 Financial Results
08 Nov 2023 //
GLOBENEWSWIRE
Societal CDMO to Report Financial Results for Third Quarter 2023
01 Nov 2023 //
GLOBENEWSWIRE
Societal CDMO Reports Inducement Grants for New Staff
05 Oct 2023 //
GLOBENEWSWIRE
Societal CDMO to Participate in RBC Capital Markets Virtual CDMO Conference
25 Sep 2023 //
GLOBENEWSWIRE
Societal CDMO lays off 26 employees, starts hiring freeze after strategy review
21 Sep 2023 //
ENDPTS
Societal CDMO Announces Corporate Restructuring
20 Sep 2023 //
GLOBENEWSWIRE
Societal CDMO Secures Project Expansion Agreements With Existing Customers
07 Sep 2023 //
GLOBENEWSWIRE
Societal CDMO Secures Project Expansion Agreements
07 Sep 2023 //
CONTRACT PHARMA
Societal CDMO Announces Closing of $8.3 Million Public Offering of Common Stock
29 Aug 2023 //
GLOBENEWSWIRE
Societal CDMO Announces Pricing of $8.3 Million Public Offering of Common Stock
24 Aug 2023 //
GLOBENEWSWIRE
Societal CDMO Announces Proposed Public Offering of Common Stock
23 Aug 2023 //
GLOBENEWSWIRE
Societal CDMO Announces Appointment of Matt Arens to Board of Directors
23 Aug 2023 //
GLOBENEWSWIRE
Societal CDMO Reports Second Quarter 2023 Financial Results
14 Aug 2023 //
GLOBENEWSWIRE
Societal CDMO Reschedules Second Quarter 2023 Financial Results
09 Aug 2023 //
GLOBENEWSWIRE
Societal CDMO to Report Financial Results for Q2 2023 on August 9, 2023
02 Aug 2023 //
GLOBENEWSWIRE
Societal CDMO Announces Expansion of Controlled Substance Manufacturing Capabilities
26 Jul 2023 //
GLOBENEWSWIRE
Societal CDMO Selected by Spinnaker to Provide CDMO Services
10 Jul 2023 //
GLOBENEWSWIRE
Societal CDMO Reports Inducement Grants for New Staff
07 Jul 2023 //
GLOBENEWSWIRE
Societal CDMO Signs Master Service Agreement with Civicascript
29 Jun 2023 //
CONTRACT PHARMA
Societal CDMO Enters Agreement With Atossa Therapeutics
23 May 2023 //
GLOBENEWSWIRE
Societal CDMO Reports First Quarter 2023 Financial Results
10 May 2023 //
GLOBENEWSWIRE
Societal CDMO to Participate in RBC Capital Markets Global Healthcare Conference
09 May 2023 //
GLOBENEWSWIRE
Societal CDMO Selected by Xequel Bio to Provide CDMO Services to Support Ongoing Clinical Development of iNexin™
08 May 2023 //
GLOBENEWSWIRE
Societal CDMO to Report Financial Results for 1Q 2023 on May 10, 2023
03 May 2023 //
GLOBENEWSWIRE
Societal CDMO Signs Project Expansion Agreements With Existing Customers
12 Apr 2023 //
GLOBENEWSWIRE
Societal CDMO Reports Inducement Grants for New Staff
06 Apr 2023 //
GLOBENEWSWIRE
Societal CDMO Selected by Longboard to Provide CDMO Services for LP352
05 Apr 2023 //
GLOBENEWSWIRE
Longboard Selects Societal CDMO to Support Clinical Development of LP352
05 Apr 2023 //
CONTRACT PHARMA
Societal CDMO Announces U.S. FDA Approval for Manufacturing of Commercial Tablet
20 Mar 2023 //
GLOBENEWSWIRE
Societal CDMO to Participate at 35th Annual Roth Conference
03 Mar 2023 //
GLOBENEWSWIRE
Societal CDMO Reports Fourth Quarter and Full Year 2022 Financial Results
01 Mar 2023 //
GLOBENEWSWIRE
Societal CDMO to Report Financial Results for Q4 and Year-End 2022 on March 1
22 Feb 2023 //
GLOBENEWSWIRE
Societal CDMO Reports Inducement Grants for New Staff
06 Jan 2023 //
GLOBENEWSWIRE
Societal CDMO Completes Strategic Recast of Capital Structure
16 Dec 2022 //
GLOBENEWSWIRE
Societal CDMO Announces Closing of $35.6 Million Concurrent Public Offerings
14 Dec 2022 //
GLOBENEWSWIRE
Societal CDMO Advances Multi-Step Strategy to Recast Capital Structur Strengthen
12 Dec 2022 //
GLOBENEWSWIRE
Societal CDMO Announces Proposed Concurrent Public Offerings of Common Stock
12 Dec 2022 //
GLOBENEWSWIRE
Societal CDMO Announces Pricing of $35.6 Million Concurrent Public Offerings
12 Dec 2022 //
GLOBENEWSWIRE
Societal CDMO 3Q Revenue up 19%
10 Nov 2022 //
CONTRACTPHARMA
Societal CDMO Reports Third Quarter 2022 Financial Results
09 Nov 2022 //
GLOBENEWSWIRE
Societal CDMO to Report Financial Results for Third Quarter 2022 in November
02 Nov 2022 //
GLOBENEWSWIRE
Cingulate Announces Agreement with Societal CDMO and Provides Clinical Update
24 Oct 2022 //
GLOBENEWSWIRE
Societal CDMO Inks New Service Agreements
20 Oct 2022 //
CONTRACTPHARMA
Societal CDMO Reports Inducement Grants for New Staff
06 Oct 2022 //
GLOBENEWSWIRE
Societal CDMO Signs Multiple Service Agreements
03 Oct 2022 //
CONTRACTPHARMA
Societal CDMO Announces Signing of Multiple Agreements With New and Existing Customers
29 Sep 2022 //
GLOBENEWSWIRE
Societal CDMO Awarded Two New CDMO Service Contracts on Supporting Ongoing
07 Sep 2022 //
GLOBENEWSWIRE
Societal CDMO Inks Land Sell Deal
16 Aug 2022 //
CONTRACTPHARMA
Societal CDMO Announces Signing of More Than $9 Mil Sales & Purchase Agreement
16 Aug 2022 //
GLOBENEWSWIRE
Societal CDMO Reports Second Quarter 2022 Financial Results
10 Aug 2022 //
GLOBENEWSWIRE
Societal CDMO wins tech transfer and production contract for HIV drug candidate
05 Aug 2022 //
PHARMA FILE
Societal CDMO Adds 3 New Customers, Signing Agreements to Provide CDMO Services
04 Aug 2022 //
GLOBENEWSWIRE
Societal CDMO to Report Financial Results for Second Quarter 2022
03 Aug 2022 //
GLOBENEWSWIRE
Societal CDMO Selected To Provide Tech Transfer And Manufacturing Services
20 Jul 2022 //
GLOBENEWSWIRE
